Rawad Hodeify
Overview
Explore the profile of Rawad Hodeify including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hodeify R, Ghani A, Matar R, Vazhappilly C, Merheb M, Zouabi H, et al.
Cell Physiol Biochem
. 2022 Sep;
56:484-499.
PMID: 36126285
Background/aims: In kidney, extracellular [Ca] can modulate intracellular [Ca] to control key cellular processes. Hence, extracellular [Ca] is normally maintained within narrow range. We tested effect of extracellular ATP on...
12.
Khalil C, Hodeify R, Kreydiyyeh S
Cell Physiol Biochem
. 2022 Aug;
56(4):418-435.
PMID: 36041048
Background/aims: In renal ischemia, the Na/K ATPase of the kidney epithelial cells translocates to intracellular compartments, resulting in altered kidney functions. Sphingosine-1-phosphate (S1P) was shown to play a protective role...
13.
Rida R, Hodeify R, Kreydiyyeh S
J Appl Toxicol
. 2022 Aug;
43(2):220-229.
PMID: 35946054
FTY720P, an analogue of sphingosine 1-phosphate, has emerged lately as a potential causative agent of inflammatory bowel disease, in which electrolytes movements driven by the sodium gradient established by the...
14.
Nader N, Dib M, Hodeify R, Courjaret R, Elmi A, Hammad A, et al.
PLoS Biol
. 2021 Feb;
19(2):e3001117.
PMID: 33566812
[This corrects the article DOI: 10.1371/journal.pbio.3000901.].
15.
Hodeify R, Siddiqui S, Matar R, Vazhappilly C, Merheb M, Zouabi H, et al.
Heliyon
. 2021 Feb;
7(1):e06041.
PMID: 33532651
Cisplatin (CDDP) is currently one of the most effective FDA-approved treatments for breast cancer. Previous studies have shown that CDDP-induced cell death in human breast cancer (MCF-7) cells is associated...
16.
Hodeify R, Dib M, Alcantara-Adap E, Courjaret R, Nader N, Reyes C, et al.
Sci Rep
. 2021 Jan;
11(1):2290.
PMID: 33504898
Regulation of Ca signaling is critical for the progression of cell division, especially during meiosis to prepare the egg for fertilization. The primary Ca influx pathway in oocytes is Store-Operated...
17.
Hodeify R, Chakkour M, Rida R, Kreydiyyeh S
PLoS One
. 2021 Jan;
16(1):e0245400.
PMID: 33444342
The Na+/K+ ATPase is a key regulator of the hepatocytes ionic homeostasis, which when altered may lead to many liver disorders. We demonstrated recently, a significant stimulation of the Na+/K+...
18.
Vazhappilly C, Hodeify R, Siddiqui S, Laham A, Menon V, El-Awady R, et al.
Phytother Res
. 2020 Dec;
35(4):2185-2199.
PMID: 33289235
Targeting cell cycle and inducing DNA damage by activating cell death pathways are considered as effective therapeutic strategy for combating breast cancer progression. Many of the naturally known small molecules...
19.
Nader N, Dib M, Hodeify R, Courjaret R, Elmi A, Hammad A, et al.
PLoS Biol
. 2020 Nov;
18(11):e3000901.
PMID: 33137110
The steroid hormone progesterone (P4) mediates many physiological processes through either nuclear receptors that modulate gene expression or membrane P4 receptors (mPRs) that mediate nongenomic signaling. mPR signaling remains poorly...
20.
Siddiqui S, Matar R, Merheb M, Hodeify R, Vazhappilly C, Marton J, et al.
Cells
. 2019 Sep;
8(10).
PMID: 31546700
Siglecs (Sialic acid-binding immunoglobulin-type lectins) are a I-type lectin that typically binds sialic acid. Siglecs are predominantly expressed in immune cells and generate activating or inhibitory signals. They are also...